Vergoeding 2015-2019 voor ATC-subgroep J05AF : Nucleoside en nucleotide reverse-transcriptaseremmers
- Raming voor de totale Zvw-populatie
| 2015 | 2016 | 2017 | 2018 | 2019 | |
|---|---|---|---|---|---|
| J05AF01 Zidovudine (Retrovir ®) | 54.545 | 46.755 | 43.341 | 32.785 | 19.823 |
| J05AF02 Didanosine (Videx ®) | 86.910 | 72.288 | 38.300 | 648 | . |
| J05AF04 Stavudine | 5.089 | 4.863 | 905 | . | . |
| J05AF05 Lamivudine (Epivir ®) | 825.310 | 723.910 | 592.750 | 529.170 | 424.490 |
| J05AF06 Abacavir (Ziagen ®) | 644.640 | 653.630 | 585.930 | 505.680 | 385.090 |
| J05AF07 Tenofovirdisoproxil (Viread ®) | 6.926.200 | 6.949.800 | 6.492.100 | 2.534.500 | 990.430 |
| J05AF08 Adefovir (Hepsera ®) | 529.460 | 431.190 | 377.140 | 340.800 | 244.900 |
| J05AF09 Emtricitabine (Emtriva ®) | 98.819 | 111.560 | 80.060 | 57.383 | 50.456 |
| J05AF10 Entecavir (Baraclude ®) | 6.453.400 | 7.099.800 | 7.479.200 | 3.425.200 | 1.483.100 |
| J05AF11 Telbivudine (Sebivo ®) | 33.261 | 21.624 | 22.045 | 24.060 | 19.588 |
| J05AF13 Tenofoviralafenamide (Vemlidy ®) | . | . | 58.458 | 519.990 | 1.101.400 |
| Totaal | 15.657.634 | 16.115.420 | 15.770.229 | 7.970.216 | 4.719.277 |